🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

UPDATE 9-England to go back into COVID-19 lockdown from midnight - BBC

Published 04-01-2021, 01:27 pm
Updated 04-01-2021, 11:18 pm
AZN
-
ITV
-
PFE
-
22UAy
-

* PM Johnson set to announce tougher restrictions

* New measures likely to come into force from midnight - BBC

* UK first to roll out AstraZeneca vaccine

* 82-year-old dialysis patient is first to get shot

* UK hails British scientific 'triumph'

* Concerns grow over South African variant (Recasts with BBC report)

By William Schomberg, Alistair Smout and Guy Faulconbridge

LONDON, Jan 4 (Reuters) - British Prime Minister Boris Johnson is set to announce later on Monday a new coronavirus lockdown for all of England similar to the one imposed when the pandemic hit the country in March, the BBC reported.

The measures would include school closures for most pupils and people would be asked to work from home unless they are unable to do their jobs remotely or are key workers, the BBC said, adding the measures would come into effect from midnight.

Johnson is due to deliver a televised address to the nation at 2000 GMT.

Earlier on Monday, his government touted a scientific "triumph" as Britain became the first country in the world to start vaccinating its population with Oxford University and AstraZeneca's AZN.L COVID-19 shot.

Dialysis patient Brian Pinker, 82, received the first Oxford/AstraZeneca shot outside of a trial.

"I am so pleased to be getting the COVID vaccine today and really proud that it is one that was invented in Oxford," said Pinker, a retired maintenance manager, just a few hundred metres from where the vaccine was developed. is grappling with the world's sixth highest death toll and one of the worst economic hits from the COVID-19 crisis. More than 75,000 people in the United Kingdom have died from COVID-19 within 28 days of a positive test.

It was the first country to roll out the vaccine developed by Pfizer (NYSE:PFE) PFE.N and Germany's BioNTech 22UAy.DE almost a month ago, and is prioritising getting a first dose of vaccines to as many people as possible over giving second doses.

Some experts say they are worried about such an approach. new variants of the coronavirus are complicating the COVID-19 response and Britain has seen a resurgence in cases to new daily highs.

UK scientists have expressed concern that the vaccines being rolled out may not be able to protect against a new variant of the coronavirus that emerged in South Africa and has spread internationally. parliament will be recalled on Wednesday to debate the lockdown measures.

Moving ahead of Johnson, Scottish First Minister Nicola Sturgeon earlier on Monday imposed the most stringent lockdown for Scotland since last spring.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.